UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 31

Sortiert nach

High sustained virologic response rates in rapid virologic response patients in the large real-world PROPHESYS cohort confirm results from randomized clinical trials

Hepatology (Baltimore, Md.), 2012-12, Vol.56 (6), p.2039-2050

2012

Link zum Volltext

Verfügbarkeit prüfen

Ribavirin and interferon alfa‐2b in chronic hepatitis C: assessment of possible pharmacokinetic and pharmacodynamic interactions

British journal of clinical pharmacology, 1998-12, Vol.46 (6), p.563-570

1998

Link zum Volltext

Verfügbarkeit prüfen

Incubation Phase of Acute Hepatitis B in Man: Dynamic of Cellular Immune Mechanisms

Hepatology (Baltimore, Md.), 2000-11, Vol.32 (5), p.1117-1124

2000

Link zum Volltext

Verfügbarkeit prüfen

Applying a system approach to forecast the total hepatitis C virus-infected population size: model validation using US data

Liver international, 2011-07, Vol.31 (s2), p.4-17

2011

Link zum Volltext

Verfügbarkeit prüfen

Non-cirrhotic thrombocytopenic patients with hepatitis C virus: Characteristics and outcome of antiviral therapy

Journal of gastroenterology and hepatology, 2015-08, Vol.30 (8), p.1301-1308

2015

Link zum Volltext

Verfügbarkeit prüfen

Safety of peginterferon alfa-2a plus ribavirin in a large multinational cohort of chronic hepatitis C patients

Liver international, 2012-09, Vol.32 (8), p.1270-1277

2012

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis C virus (HCV) tends to associate preferentially with high-density lipoproteins by standard ultracentrifugal fractionation of plasma from patients with chronic HCV infection

Hepatology research, 1998-07, Vol.11 (3), p.158-165

1998

Link zum Volltext

Verfügbarkeit prüfen

Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine

Hepatology (Baltimore, Md.), 1996-09, Vol.24 (3), p.711-713

1996

Link zum Volltext

Verfügbarkeit prüfen

Treatment of chronic type B and C hepatitis with interferon alfa: An economic appraisal

Hepatology (Baltimore, Md.), 1995, Vol.22 (6), p.1863-1873

1995

Link zum Volltext

Verfügbarkeit prüfen

The pathology of hepatitis C

Hepatology (Baltimore, Md.), 1992-04, Vol.15 (4), p.567-571

1992

Link zum Volltext

Verfügbarkeit prüfen

Treatment of chronic type B and C hepatitis with interferon alfa: An economic appraisal

Hepatology (Baltimore, Md.), 1995-12, Vol.22 (6), p.1863-1873

1995

Link zum Volltext

Verfügbarkeit prüfen

Treatment of chronic hepatitis C with consensus interferon: A multicenter, randomized, controlled trial

Hepatology (Baltimore, Md.), 1997-09, Vol.26 (3), p.747-754

1997

Link zum Volltext

Verfügbarkeit prüfen

Biodistribution, stability, and antiviral efficacy of liposome‐entrapped phosphorothioate antisense oligodeoxynucleotides in ducks for the treatment of chronic duck hepatitis B virus infection

Hepatology (Baltimore, Md.), 1998-11, Vol.28 (5), p.1402-1410

1998

Link zum Volltext

Verfügbarkeit prüfen

Epirubicin-lipiodol chemotherapy versus131iodine-lipiodol radiotherapy in the treatment of unresectable hepatocellular carcinoma

Cancer, 1995-12, Vol.76 (11), p.2202-2210

1995

Link zum Volltext

Verfügbarkeit prüfen

Acyclovir in chronic hepatitis B virus infection

Hepatology (Baltimore, Md.), 1988-11, Vol.8 (6), p.1714-1715

Dusheiko, Geoffrey M.

1988

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis C virus-polymerase chain reaction of routinely processed liver biopsies

Journal of medical virology, 1994-08, Vol.43 (4), p.380-385

1994

Link zum Volltext

Verfügbarkeit prüfen

Epirubicin‐lipiodol chemotherapy versus 131iodine‐lipiodol radiotherapy in the treatment of unresectable hepatocellular carcinoma

Cancer, 1995-12, Vol.76 (11), p.2202-2210

1995

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis B Virus Replication in Southern African Blacks with HBsAg‐Positive Hepatocellular Carcinoma

Hepatology (Baltimore, Md.), 1984-07, Vol.4 (4), p.608-610

1984

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis B Virus Status of Southern African Blacks with Hepatocellular Carcinoma: Comparison Between Rural and Urban Patients

Hepatology (Baltimore, Md.), 1983, Vol.3 (1), p.65-68

1983

Link zum Volltext

Verfügbarkeit prüfen

Cyclic nucleotides in biological fluids in hepatocellular carcinoma

Cancer, 1981-01, Vol.47 (1), p.113-118

1981

Link zum Volltext

Verfügbarkeit prüfen

Adenine arabinoside 5′‐monophosphate treatment of chronic type B hepatitis

Hepatology (Baltimore, Md.), 1982-11, Vol.2 (6), p.784-788

1982

Link zum Volltext

Verfügbarkeit prüfen

Global Burden of Disease (GBD) for Hepatitis C

Journal of clinical pharmacology, 2004-01, Vol.44 (1), p.20-29

The Global Burden Of Hepatitis C Working Group

2004

Link zum Volltext

Verfügbarkeit prüfen

The dynamics of T-lymphocyte responses during combination therapy for chronic hepatitis C virus infection

Hepatology (Baltimore, Md.), 2002-09, Vol.36 (3), p.743-754

2002

Link zum Volltext

Verfügbarkeit prüfen

Tenofovir disoproxil fumarate in Asian or Pacific Islander chronic hepatitis B patients with high viral load (≥ 9 log10 copies/ml)

Liver international, 2015-02, Vol.35 (2), p.422-428

2015

Link zum Volltext

Verfügbarkeit prüfen

Ultra‐sensitive class I tetramer analysis reveals previously undetectable populations of antiviral CD8+ T cells

European journal of immunology, 2004-06, Vol.34 (6), p.1570-1577

2004

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 31

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library Full Collection 2018

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(31)

Sprache

Englisch
(31)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

3 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

High sustained virologic response rates in rapid virologic response patients in the large real-world PROPHESYS cohort confirm results from randomized clinical trials

Ribavirin and interferon alfa‐2b in chronic hepatitis C: assessment of possible pharmacokinetic and pharmacodynamic interactions

Incubation Phase of Acute Hepatitis B in Man: Dynamic of Cellular Immune Mechanisms

Applying a system approach to forecast the total hepatitis C virus-infected population size: model validation using US data

Non-cirrhotic thrombocytopenic patients with hepatitis C virus: Characteristics and outcome of antiviral therapy

Safety of peginterferon alfa-2a plus ribavirin in a large multinational cohort of chronic hepatitis C patients

Hepatitis C virus (HCV) tends to associate preferentially with high-density lipoproteins by standard ultracentrifugal fractionation of plasma from patients with chronic HCV infection

Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine

Treatment of chronic type B and C hepatitis with interferon alfa: An economic appraisal

The pathology of hepatitis C

Treatment of chronic type B and C hepatitis with interferon alfa: An economic appraisal

Treatment of chronic hepatitis C with consensus interferon: A multicenter, randomized, controlled trial

Biodistribution, stability, and antiviral efficacy of liposome‐entrapped phosphorothioate antisense oligodeoxynucleotides in ducks for the treatment of chronic duck hepatitis B virus infection

Epirubicin-lipiodol chemotherapy versus131iodine-lipiodol radiotherapy in the treatment of unresectable hepatocellular carcinoma

Acyclovir in chronic hepatitis B virus infection

Hepatitis C virus-polymerase chain reaction of routinely processed liver biopsies

Epirubicin‐lipiodol chemotherapy versus 131iodine‐lipiodol radiotherapy in the treatment of unresectable hepatocellular carcinoma

Hepatitis B Virus Replication in Southern African Blacks with HBsAg‐Positive Hepatocellular Carcinoma

Hepatitis B Virus Status of Southern African Blacks with Hepatocellular Carcinoma: Comparison Between Rural and Urban Patients

Cyclic nucleotides in biological fluids in hepatocellular carcinoma

Adenine arabinoside 5′‐monophosphate treatment of chronic type B hepatitis

Global Burden of Disease (GBD) for Hepatitis C

The dynamics of T-lymphocyte responses during combination therapy for chronic hepatitis C virus infection

Tenofovir disoproxil fumarate in Asian or Pacific Islander chronic hepatitis B patients with high viral load (≥ 9 log10 copies/ml)

Ultra‐sensitive class I tetramer analysis reveals previously undetectable populations of antiviral CD8+ T cells

Aktive Filter

Suchergebnisse filtern